Your browser doesn't support javascript.
loading
Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial.
Albain, Kathy S; Barlow, William E; Ravdin, Peter M; Farrar, William B; Burton, Gary V; Ketchel, Steven J; Cobau, Charles D; Levine, Ellis G; Ingle, James N; Pritchard, Kathleen I; Lichter, Allen S; Schneider, Daniel J; Abeloff, Martin D; Henderson, I Craig; Muss, Hyman B; Green, Stephanie J; Lew, Danika; Livingston, Robert B; Martino, Silvana; Osborne, C Kent.
Affiliation
  • Albain KS; Loyola University Stritch School of Medicine, Maywood, IL, USA. Electronic address: kalbain@lumc.edu.
  • Barlow WE; Southwest Oncology Group Statistical Center, Seattle, WA, USA.
  • Ravdin PM; University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
  • Farrar WB; Ohio State University Health Center, Columbus, OH, USA.
  • Burton GV; Louisiana State University, Shreveport, LA, USA.
  • Ketchel SJ; University of Arizona Cancer Center, Tucson, AZ, USA.
  • Cobau CD; Flower Memorial Hospital, Sylvania, OH, USA.
  • Levine EG; Roswell Park Cancer Institute, Buffalo, NY, USA.
  • Ingle JN; Mayo Clinic, Rochester, MN, USA.
  • Pritchard KI; Toronto Sunnybrook Regional Cancer Centre, Toronto, ON, USA.
  • Lichter AS; University of Michigan, Ann Arbor, MI, USA.
  • Schneider DJ; Loyola University Stritch School of Medicine, Maywood, IL, USA.
  • Abeloff MD; Johns Hopkins Medical Center, Baltimore, MD, USA.
  • Henderson IC; University of California, San Francisco, San Francisco, CA, USA.
  • Muss HB; Vermont Cancer Center and University of Vermont, Burlington, VT, USA.
  • Green SJ; Southwest Oncology Group Statistical Center, Seattle, WA, USA.
  • Lew D; Southwest Oncology Group Statistical Center, Seattle, WA, USA.
  • Livingston RB; University of Arizona Cancer Center, Tucson, AZ, USA.
  • Martino S; The Angeles Clinic and Research Institute, Santa Monica, CA, USA.
  • Osborne CK; Baylor College of Medicine, Houston, TX, USA.
Lancet ; 374(9707): 2055-2063, 2009 Dec 19.
Article in En | MEDLINE | ID: mdl-20004966
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tamoxifen / Breast Neoplasms / Adenocarcinoma / Antineoplastic Agents, Hormonal / Lymph Nodes Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Lancet Year: 2009 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tamoxifen / Breast Neoplasms / Adenocarcinoma / Antineoplastic Agents, Hormonal / Lymph Nodes Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Lancet Year: 2009 Document type: Article